TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹4,717 Cr | ₹5,425 Cr | ₹5,447 Cr | ₹4,415 Cr | ₹4,892 Cr |
What is the latest Total Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹4,717 Cr |
Mar2024 | ₹5,425 Cr |
Mar2023 | ₹5,447 Cr |
Mar2022 | ₹4,415 Cr |
Mar2021 | ₹4,892 Cr |
How is Total Current Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4,717 Cr | -13.05 | |
Mar2024 | ₹5,425 Cr | -0.40 | |
Mar2023 | ₹5,447 Cr | 23.38 | |
Mar2022 | ₹4,415 Cr | -9.74 | |
Mar2021 | ₹4,892 Cr | - |
Compare Total Current Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹121,717.4 Cr | -2.1% | 7.2% | 9.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -1.9% | -4.1% | -6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -3.6% | -12.3% | 27.1% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -0.7% | -0% | -2.9% | Stock Analytics | |
MANKIND PHARMA | ₹104,912.0 Cr | -0.8% | 0.7% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -1.6% | -5.4% | -12.1% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -2.1% |
7.2% |
9.3% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses